UNSPSC 51101902: Mefloquine

This classification denotes an antimalarial agent with the molecular formula C17H16F6N2O, a preparation that US FDA regulates as an active ingredient or moiety under Unique Ingredient Identifier TML814419R, chemically known as 4-quinolinemethanol, .alpha.-2-piperidinyl-2,8-bis(trifluoromethyl)-, (r*,s*)-(.+/-.)- but generally known as mefloquine, which bears US NIH Compound Identifier 4046. European Medicines Agency schedules Mefloquine in its eXtended EudraVigilance Medicinal Product Dictionary or XEVMPD under Index SUB08709MIG.

UNSPSC 51101902 Mefloquine is a Commodity code that nominally identifies a specific antimalarial pharmaceutical, but recent state and local solicitations under this code show little activity aligned with mefloquine itself. Instead, the code tags a diverse range of pharmaceutical and medical supply procurements — naloxone systems, generic pharmaceuticals through cooperative wholesaler networks, and emergency medical consumables — suggesting either broad mis-tagging in state procurement systems or that the code serves as a catch-all for pharmaceutical commodities beyond its formal definition. State and local buyers posting under this code include county health departments, state health and human services commissions, cities, and cooperative purchasing alliances. Issuing bodies range from individual municipalities and counties (Seminole County, Florida; City of Tampa) to state-level health agencies and multistate cooperative vehicles (Texas Health and Human Services Commission; Minnesota Multistate Cooperative Purchasing Alliance serving multiple states including Oregon). The work being solicited encompasses annual purchases of emergency response drugs and harm-reduction equipment, first-aid and rescue supplies for fire departments, and bulk generic pharmaceuticals distributed through authorized pharmaceutical wholesalers to government facilities.

Recent activity shows geographic concentration in the South and Midwest. Seminole County, Florida solicited naloxone and drug deactivation systems through IFB 60459723LAS with a response deadline of July 26, 2023 (posting date June 30, 2026), requesting 1,900 units of naloxone and 800 deactivation systems annually with quarterly deliveries. The City of Tampa issued IFB 26P00145 for medical and first aid supplies (due March 13, 2026) covering 169 line items for the Fire Department Rescue Division, with an estimated contract value of $700,000 and a sheltered-market set-aside for certified Small Local Business Enterprises at a 5 percent bid discount. The Texas Health and Human Services Commission posted RFI HHS0017013 (due April 3, 2026) to gather vendor capabilities on direct-to-manufacturer prescription programs outside traditional pharmacy benefit manager channels. The Minnesota Multistate Cooperative Purchasing Alliance issued RFP S1070000015802 (due March 26, 2026) for generic multi-source pharmaceuticals and OTC products distributed through AmerisourceBergen, Cardinal Health, and Morris & Dickson, with vendor pricing weighted at 75 percent of evaluation criteria and a July 1, 2026 contract effective date.